Treat to Target Outcomes in Early AxSpA Save
Dr. Antoni Chan discusses abstract OP0132, "TREAT-TO-TARGET APPROACH ALLOWS TO INDUCE SUSTAINED CLINICAL REMISSION IN OVER 60% OF PATIENTS WITH EARLY AXIAL SPONDYLOARTHRITIS", presented at Eular 2024 in Vienna, Austria.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.